Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
0.9500
+0.4514 (90.53%)
Apr 17, 2025, 11:51 AM EDT
Silence Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 121.33 | 68.79 | 66.05 | 73.54 | 27.45 | Upgrade
|
Short-Term Investments | 26 | - | 19.67 | - | 10 | Upgrade
|
Cash & Short-Term Investments | 147.33 | 68.79 | 85.72 | 73.54 | 37.45 | Upgrade
|
Cash Growth | 114.18% | -19.75% | 16.57% | 96.37% | 11.73% | Upgrade
|
Accounts Receivable | 0.97 | 0.29 | 1.1 | 0.33 | 29.31 | Upgrade
|
Other Receivables | 25.94 | 23.69 | 19.79 | 8.16 | 4.21 | Upgrade
|
Receivables | 26.91 | 23.98 | 20.9 | 8.49 | 33.52 | Upgrade
|
Prepaid Expenses | 13.12 | 10.39 | 9.88 | 4.31 | 3.94 | Upgrade
|
Other Current Assets | - | - | - | - | 1.49 | Upgrade
|
Total Current Assets | 187.37 | 103.15 | 116.5 | 86.33 | 76.4 | Upgrade
|
Property, Plant & Equipment | 1.98 | 2.31 | 2.65 | 1.94 | 1.13 | Upgrade
|
Long-Term Investments | - | - | 0.34 | 0.3 | 0.3 | Upgrade
|
Goodwill | 9.39 | 9.98 | 9.65 | 7.59 | 8.13 | Upgrade
|
Other Intangible Assets | 0.31 | 0.36 | 0.39 | 0.02 | 0.02 | Upgrade
|
Other Long-Term Assets | 3.59 | 3.65 | - | - | - | Upgrade
|
Total Assets | 202.64 | 119.45 | 129.53 | 96.19 | 85.97 | Upgrade
|
Accounts Payable | 3.7 | 3.35 | 3.84 | 4.07 | 2.29 | Upgrade
|
Accrued Expenses | 12.05 | 11.72 | 10.67 | 6.53 | 5.91 | Upgrade
|
Current Portion of Leases | 0.12 | 0.23 | 0.54 | 0.14 | 0.34 | Upgrade
|
Current Income Taxes Payable | 0.65 | 0.47 | 0.71 | 0.19 | - | Upgrade
|
Current Unearned Revenue | 0.31 | 6.57 | 10.68 | 4.25 | 17.04 | Upgrade
|
Total Current Liabilities | 16.82 | 22.34 | 26.44 | 15.17 | 25.58 | Upgrade
|
Long-Term Leases | - | 0.12 | - | - | - | Upgrade
|
Long-Term Unearned Revenue | 51.79 | 75 | 76.49 | 72.5 | 51.34 | Upgrade
|
Total Liabilities | 68.61 | 97.46 | 102.93 | 87.67 | 76.91 | Upgrade
|
Common Stock | 10.29 | 8.85 | 6.49 | 4.49 | 4.17 | Upgrade
|
Additional Paid-In Capital | 609.56 | 455.77 | 273.11 | 184.33 | 153.73 | Upgrade
|
Retained Earnings | -485.83 | -442.62 | -317.2 | -222.97 | -184.22 | Upgrade
|
Comprehensive Income & Other | - | - | 64.19 | 42.67 | 35.38 | Upgrade
|
Shareholders' Equity | 134.02 | 21.99 | 26.59 | 8.53 | 9.06 | Upgrade
|
Total Liabilities & Equity | 202.64 | 119.45 | 129.53 | 96.19 | 85.97 | Upgrade
|
Total Debt | 0.12 | 0.35 | 0.54 | 0.14 | 0.34 | Upgrade
|
Net Cash (Debt) | 147.22 | 68.44 | 85.18 | 73.4 | 37.11 | Upgrade
|
Net Cash Growth | 115.09% | -19.65% | 16.05% | 97.80% | 11.67% | Upgrade
|
Net Cash Per Share | 3.18 | 1.85 | 2.65 | 2.48 | 1.36 | Upgrade
|
Filing Date Shares Outstanding | 47.22 | 46.5 | 35.95 | 29.93 | 27.77 | Upgrade
|
Total Common Shares Outstanding | 47.22 | 39.62 | 35.94 | 29.93 | 27.77 | Upgrade
|
Working Capital | 170.54 | 80.82 | 90.06 | 71.17 | 50.82 | Upgrade
|
Book Value Per Share | 2.84 | 0.56 | 0.74 | 0.28 | 0.33 | Upgrade
|
Tangible Book Value | 124.32 | 11.65 | 16.56 | 0.91 | 0.92 | Upgrade
|
Tangible Book Value Per Share | 2.63 | 0.29 | 0.46 | 0.03 | 0.03 | Upgrade
|
Machinery | 6.34 | 6.44 | 6.01 | 5.11 | 4.07 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.